New lung cancer drug shows dramatic results for shrinking tumors: Phase III clinical trial being offered
Tuesday, June 22, 2010 - 14:31
in Health & Medicine
Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial being offered. The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumors in some patients during Phase I and II clinical trials.